Augmentative and Alternative Communication in Games With Virtual Reality in Intellectual Disabilities
NCT ID: NCT03033797
Last Updated: 2017-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
165 participants
INTERVENTIONAL
2016-03-08
2018-03-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Virtual Reality Games Using Head-mounted Display on Patients With Brain Disorders
NCT03196739
Eye-tracking Working Memory Training in Children and Youth With Severe Cerebral Palsy
NCT06918379
A Computerized, Adaptive Therapeutic Gaming Approach Training Visual Perceptual Skills in Children With CVI
NCT05014503
Outcomes Measures in Intellectual Disability
NCT03878251
Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders
NCT06838975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MoviLetrando-MoveHero
Half of the children will play first two different levels of the game MoviLetrando (2 minutes each) and, after the game MoveHero, more 2 minutes
MoviLetrando
Half of the participants will play two different levels of the Game MoviLetrando, two minutes each.
MoveHero
Half of the participants will play 2 minutes of the game MoveHero.
MoveHero-MoviLetrando
The other half of the children will play first 2 minutes of the game MoveHero and after, two different levels of the Game MoviLetrando, two minutes each.
MoviLetrando
Half of the participants will play two different levels of the Game MoviLetrando, two minutes each.
MoveHero
Half of the participants will play 2 minutes of the game MoveHero.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MoviLetrando
Half of the participants will play two different levels of the Game MoviLetrando, two minutes each.
MoveHero
Half of the participants will play 2 minutes of the game MoveHero.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those who are not present in the two days of evaluation.
7 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculdade de Medicina do ABC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Regiani Guarnieri
Graphic Computer Specialist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Associação de Pais e Amigos dos Excepcionais
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
54172416.6.0000.0082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.